Regarding the article by Furukawa et al.
D001249:Asthma / Q000188:drug therapy*; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D007859:Learning Disabilities / Q000139:chemically induced*; D001523:Mental Disorders / Q000139:chemically induced*; D013806:Theophylline / Q000009:adverse effects*
D013806:Theophylline; D004205:Cromolyn Sodium